Skip to main content

Reporter April 8 2022

Financial impact of prior authorization

Apr. 12, 2022—Prior authorization — health insurer approval of a medical intervention prior to treatment — costs more than $40 million for U.S. academic radiation oncology practices, with questionable value added to patient care.

Read more


Peptides promote AFib arrhythmia

Apr. 11, 2022—Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation.

Read more


New Clinician Spotlight: Nick Strasser

Apr. 7, 2022—Nicholas Strasser, MD, recently joined Vanderbilt University Medical Center as assistant professor of Orthopaedics in the Division of Foot and Ankle Surgery.

Read more


Computer eyeballs graft-vs-host disease

Apr. 7, 2022—A machine learning algorithm identified areas of skin affected by chronic graft-versus-host disease on par with clinicians, opening the door to streamlining and standardizing this measure of patient response to therapy.

Read more


New prognosis predictor and target for gastric cancer

Apr. 7, 2022—The protein CGA — a subunit of glycoprotein hormones — is a biomarker that predicts chemoresistance in gastric cancer and could be targeted along with EGFR to restore chemosensitivity.

Read more


Study advances understanding of bacterial bioterrorism agent

Apr. 7, 2022—Vanderbilt researchers have identified a critical regulatory factor in the bacterium that causes the disease anthrax and has been used as a biological weapon.

Read more


Transplant Pharmacy program helps track medication adherence

Apr. 7, 2022—A computer program developed by VUMC transplant pharmacists and pharmacy IT technicians is helping patients adhere to the often-strict medication regimens required after undergoing a transplant.

Read more


Study explores parents’ reluctance to flu, COVID vaccines for children

Apr. 7, 2022—Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children.

Read more


Event highlights research on Alzheimer’s disease

Apr. 7, 2022—The third annual Vanderbilt Alzheimer’s Disease Research Day featured numerous presentations and concluded with a keynote address by Suzanne Craft, PhD, director of the Alzheimer’s Disease Research Center at Wake Forest University.

Read more


Vanderbilt Prize winner Regev to deliver April 14 Discovery Lecture

Apr. 7, 2022—Aviv Regev, PhD, recipient of the 2021 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Discovery Lecture at 4 p.m. next Thursday, April 14, in 208 Light Hall.

Read more


Friends & Fashion event returns to the runway

Apr. 7, 2022—After a two-year break due to the COVID-19 pandemic, Friends & Fashion returned in style to raise funds for Monroe Carell Jr. Children's Hospital at Vanderbilt.

Read more


Patient’s amyloidosis awareness efforts recognized

Apr. 7, 2022—Charlotte Haffner, who was Vanderbilt's first patient to undergo a heart transplant followed by a stem cell transplant to treat primary AL amyloidosis, was recently recognized by Williamson County Mayor Rogers Anderson and Franklin Mayor Ken Moore.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more